Sentences with phrase «supported by the allergy»

The study — conducted by the Clinical Investigator Collaborative, a multi-centre, Phase II clinical trials group supported by the Allergy, Genes and Environment Network (AllerGen)-- recruited 31 patients over five sites across Canada.

Not exact matches

KFA is dedicated to keeping children with food allergies safe and healthy by educating and supporting their families and the community.

asthma and allergy friendly ® Certification Program: Corporations also support AAFA's mission by their participation in the asthma and allergy friendly ® Certification Program.

Buffalo, NY - The Erie County Legislature unanimously passed a resolution introduced by Peter J. Savage III (D - Buffalo & Tonawanda) supporting the Emergency Allergy Treatment Act.

This work was supported by grant numbers R01AR069502 and R21AI126896 to Miller and 1DP2OD008752 to Maverakis, by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, and an early career award from the Burroughs Wellcome Fund.

The work was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health.

Support for this study was provided by the Food Allergy Science Initiative (FASI); the Klarman Family Foundation; the National Institute of Allergy and Infectious Diseases; the National Heart, Lung, and Blood Institute; the Howard Hughes Medical Institute; and other sources.

The study, published today in Nature, was supported by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, and other organizations.

The research was supported by the Burroughs Welcome Fund, The Skaggs Institute of Chemical Biology at TSRI, the National Institutes of Health's National Institute of Allergy and Infectious Diseases (numbers R43 AI1088843, 2T32AI007244 and U54 AI057153), the Japan Society for the Promotion of Science and the Japanese Ministry of Education, Culture, Sports, Science and Technology.

The work was partly supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Center for Advancing Translational Sciences, both part of the National Institutes of Health.

The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The contract was with the National Institute of Allergy and Infectious Diseases and the moratorium only applies to chimpanzees that are owned or supported by NIH's National Center for Research Resources.

Support was provided by the National Institute of Allergy and Infectious Diseases, the Bloomberg Philanthropies, CNRS, Inserm, the University of Strasbourg, Agence Nationale de la Recherche, and the Johns Hopkins Malaria Research Institute.

The research, conducted by investigators supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, suggests that similar vaccines for people could be similarly protective.

The study is supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

The research was supported in part by three grants from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health — grants AI109711, AI109762 and AI067927 — and by a Defense Threat Reduction Agency award, HDTRA1 -13-1-0034.

The research was supported, in part, by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

This idea is also supported by the researchers» finding that when neonatal mice were allowed to grow into adults without pTreg cells, i.e., without exposure to solid food, they «become much more susceptible to experimentally induced food allergy.

The research, supported by the National Institute of Allergy and Infectious Diseases Atopic Dermatitis Research Network, appeared in the February 22, 2018, issue of the journal JCI Insight.

The research was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The study was supported by a grant (AI26170) from National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

The study was supported by an Alfred P. Sloan Foundation Research Fellowship, National Institutes of Health (NIH) Director's New Innovator Award (LM011952 - 01), the Harvard Laboratory of Systems Pharmacology Center (GM107618, National Institute of General Medical Sciences of the NIH), the National Institute of Allergy and Infectious Disease of the NIH (AI114952), and Turkish Academy of Sciences GEBIP Fellowship and TUBITAK 115S934 Grant.

The paper's lead author, Dr Carsten Flohr, whose work is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas» and King's College London, said: «The WHO recommends between four and six months of exclusive breastfeeding to aid prevention of allergy and associated illnesses.

This research was supported in part by the National Institutes of Health's National Institute of Allergy and Infectious Diseases.

Research reported in this release was supported by grants from the National Institute of Allergy and Infectious Disease under award numbers AI - 051560 and AI - 093369.

This work was supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(AR060873, AI068730, AI095466, AI09560, AI097333, U01 AI095608, AR057217) and the University of Pennsylvania Skin Disease Research Center.

SK is supported by the California HIV / AIDS research program and the National Institute of Allergy and Infectious Diseases.

Support for this study was provided by Marc and Lynne Benioff, the National Institute of Allergy and Infectious Diseases, and other sources.

This work was supported by the National Institute of Allergy and Infectious Disease through interagency agreement Y1 - AI -8494-01 and the National Institute for General Medical Sciences.

The work was supported by La Jolla Institute for Allergy and Immunology, the American Heart Association (13POST16990031 and 14GRNT20500029), the American Diabetes Association (# 712MN13), the National Institutes of Health (P01 HL055798, HL136275, HL118765 HL112276, HL127649, AI089624, AI072543, AI125279, and S10 RR02736601A1).

This project was supported by the NIH National Institute of Allergy and Infectious diseases, through an R21 grant (AI108953).

The study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, the Klarman Family Foundation, the Howard Hughes Medical Institute, the Food Allergy Science Initiative, the Human Frontiers Science Program, Crohn's & Colitis Foundation, and the Leona M. and Harry B. Helmsley Charitable Trust.

This work was supported by the National Institute of Allergy and Infectious Diseases (interagency agreement number Y1 - AI - 8401), the NIH National Center for Research Resources, and the U.S. Department of Energy Office of Biological and Environmental Research.

This research was supported by the NIH (R01 AR062368, R01 AR062920 to A.J.G and R01 DK055679, R01 DK059888, DK055679, DK059888, and DK089763 to A.N.), and J.R.S. is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of Georgia.

Funding: Research performed by the authors and summarized in this report was supported by Public Health Service Contract NO1 AI 30039 from the National Institute of Allergy and Infectious Diseases.

Funding: Site development and the conduct of the trial were supported by contract N01AI85346 and cooperative agreement U19AI065683 from the National Institute of Allergy and Infectious Diseases (NIAID), grant D43TW001589 from the Fogarty International Center, National Institutes of Health, and contract W81XWH -06-1-0427 from the United States Department of Defense and the United States Agency for International Development (USAID).

Sponsors: This work was supported by the National Institute of Allergy and Infectious Disease.

The study was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, under contract number N01 AI40030.

Sponsor: The work is supported by Laboratory Directed Research and Development at PNNL and by the National Institute of Allergy and Infectious Diseases.

The clinical trial is part of the Vaccine and Treatment Evaluation Units (VTEUs), supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH).

This work was supported by the National Institute of Allergy and Infectious Diseases.

About the research study This project was supported by the NIH National Institute of Allergy and Infectious diseases, through an R21 grant (AI108953).

The work was supported by the La Jolla Institute for Allergy and Immunology, the American Heart Association, the LJI Board of Directors Fellowship, the Fondation Leducq, the Sigrid Juselius Foundation, the Academy of Finland, the Pacific Northwest Udall Center and the National Institutes of Health (R01 DK091183 - 21 and R01 HL118765.)

The NEJM study was supported by the National Institute of Allergy and Infectious Diseases, the Bill and Melinda Gates Foundation and the PATH Malaria Vaccine Initiative.

The research was supported by the National Institute of Allergy and Infectious Diseases (NIAID); the Ragon Institute of MGH, MIT, and Harvard; and MHRP.

The study is sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded), with support from the Juvenile Diabetes Research Foundation.

Acknowledgments: This research was supported by the National Institute of Allergy and Infectious Diseases, and the National Center for Research Resources.

The LEAP study, designed and conducted by the ITN with additional support from FARE and led by Professor Gideon Lack at Kings College London, is the first randomized trial to prevent food allergy in a large cohort of high - risk infants.

The research was supported by grants from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Swiss National Foundation, the Novartis Foundation, the Cystic Fibrosis Foundation, and a graduate research fellowship from the National Science Foundation.

And interestingly — unlike the other popular allergy products — this remedy works not by suppressing allergy symptoms, but rather by helping to support the body's reaction to allergens.